Is Angiotensin II a Direct Mediator of Left Ventricular Hypertrophy?: Time for Another Look

Hypertension - United States
doi 10.1161/hypertensionaha.106.075085
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Role of Cardiac Angiotensin II in Isoproterenol-Induced Left Ventricular Hypertrophy.

Hypertension
Internal Medicine
1992English

Influence of the Angiotensin II Antagonist Valsartan on Left Ventricular Hypertrophy in Patients With Essential Hypertension Response

Circulation
Cardiovascular MedicinePhysiologyCardiology
1999English

Unexplained Left Ventricular Hypertrophy

Clinical pharmacology and therapy
2019English

Effect of Angiotensin II AT1 Antagonist, Candesartan on Left Ventricular Hypertrophy and Glucose Tolerance in Essential Hypertension Patient.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1999English

Update on Left Ventricular Hypertrophy

Kardiovaskulare Medizin
Cardiovascular MedicineCardiology
2005English

Genetic Variation in Angiotensin-Converting Enzyme 2 Gene Is Associated With Extent of Left Ventricular Hypertrophy in Hypertrophic Cardiomyopathy

Human Genetics
Genetics
2008English

Spironolactone Is Secure and Reduces Left Ventricular Hypertrophy in Hemodialysis Patients

Therapeutic Advances in Cardiovascular Disease
Cardiovascular MedicinePharmacologyCardiology
2015English

Out-Of-Hemodialysis-Unit Blood Pressure Is a Superior Determinant of Left Ventricular Hypertrophy

Hypertension
Internal Medicine
2006English

Training Related Left Ventricular Hypertrophy in a Soldier

Journal of the Royal Army Medical Corps
Medicine
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy